PROTEOSTASIS THERAPEUTICS, INC. (42) | Uncategorized (10)

Recent Contracts

Open Market Sale Agreement SM, dated April 8, 2021, by and between Yumanity Therapeutics, Inc., and Jefferies LLC (Filed With SEC on April 8, 2021)
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 31, 2021)
Form of Support Agreement, by and between Proteostasis Therapeutics, Inc., Yumanity Therapeutics, Inc. and Yumanity Holdings, LLC (Filed With SEC on September 23, 2020)
Form of CVR Agreement by and between PTI and the CVR Rep (Filed With SEC on August 24, 2020)
Form of PTI Support Agreement, dated August 22, 2020, by and between Yumanity, PTI and each of the parties named in each agreement therein (Filed With SEC on August 24, 2020)
Form of Yumanity Support Agreement, dated August 22, 2020, by and between PTI, Yumanity and each of the parties named in each agreement therein (Filed With SEC on August 24, 2020)
Form of PTI Lock-Up Agreement, dated August 22, 2020, by each of the parties named in each agreement therein (Filed With SEC on August 24, 2020)
Form of Yumanity Lock-Up Agreement, dated August 22, 2020, by each of the parties named in each agreement therein (Filed With SEC on August 24, 2020)
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 10, 2020)
Form of Amended and Restated Executive Agreement (Filed With SEC on March 10, 2020)